Bunge Global (NYSE:BG – Get Free Report) issued an update on its FY 2024 earnings guidance on Wednesday morning. The company provided EPS guidance of 9.250- for the period, compared to the consensus EPS estimate of 9.430. The company issued revenue guidance of -. Bunge Global also updated its FY24 guidance to at least $9.25 EPS.
Analyst Upgrades and Downgrades
Separately, Citigroup downgraded shares of Bunge Global from a “buy” rating to a “neutral” rating and lowered their price objective for the stock from $125.00 to $114.00 in a research report on Thursday, August 1st. Four investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $118.00.
Get Our Latest Analysis on Bunge Global
Bunge Global Trading Down 1.7 %
Bunge Global (NYSE:BG – Get Free Report) last issued its earnings results on Wednesday, October 30th. The basic materials company reported $2.29 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.18 by $0.11. Bunge Global had a return on equity of 13.71% and a net margin of 2.11%. The business had revenue of $12.91 billion during the quarter, compared to the consensus estimate of $12.68 billion. Equities research analysts expect that Bunge Global will post 9.35 EPS for the current year.
About Bunge Global
Bunge Global SA operates as an agribusiness and food company worldwide. It operates through four segments: Agribusiness, Refined and Specialty Oils, Milling, and Sugar and Bioenergy. The Agribusiness segment purchases, stores, transports, processes, and sells agricultural commodities and commodity products, including oilseeds primarily soybeans, rapeseed, canola, and sunflower seeds, as well as grains comprising wheat and corn; and processes oilseeds into vegetable oils and protein meals.
Recommended Stories
- Five stocks we like better than Bunge Global
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Battle of the Retailers: Who Comes Out on Top?
- The Most Important Warren Buffett Stock for Investors: His Own
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- 3 Warren Buffett Stocks to Buy Now
- MarketBeat Week in Review – 10/28 – 11/1
Receive News & Ratings for Bunge Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bunge Global and related companies with MarketBeat.com's FREE daily email newsletter.